[1]
Celesia, B., Marino, A., Fontana del Vecchio, R., Bruno, R., Palermo, F., Gussio, M., Nunnari, G. and Cacopardo, B. 2019. IS IT SAFE AND COST SAVING TO DEFER THE CD4+ CELL COUNT MONITORING IN STABLE PATIENTS ON ART WITH MORE THAN 350 OR 500 CELLS/┬ÁL?. Mediterranean Journal of Hematology and Infectious Diseases. 11, 1 (Oct. 2019), e2019063. DOI:https://doi.org/10.4084/mjhid.2019.063.